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The preimplantation status, postimplantation morbidlty and causes of 
late mortality were summarized for 246 patients who underwent pacing 
for atrioventricular (A-V) block at the University of Michigan for the 14 
years from 1961 to 1974. The survival rate at 1,s and 10 years was 88, 
61 and 49 percent, respectively. Risk of death was greatest among pa- 
tients with antecedent ischemic or hypertensive heart disease or con- 
gestive heart failure In the period before pacemaker implantation, patients 
older than 74 years at inttlal implantation and those receiving a pacemaker 
before 1965. Forty-two percent of the 109 deaths were related to apparent 
progression of underlying cardiac disease. Pacing system malfunction 
was a contributing documented cause of only 3 deaths. Even with per- 
manent pacemaker implantation, patients with A-V block have a higher 
age-specific mortality rate than the general U.S. population. Survival 
improved steadily over the period of study. This change is attributed to 
apparent improvements in treatment of cardiovascular disease including 
more effective treatment of congestive heart failure and valve replacement 
for selected patients as well as elimination of immediate postoperative 
mortality. 
Permanent ventricular pacing has been the recognized treatment for 
atrioventricular (A-V) block for more than 15 years. Previous reports14 
have documented the continued morbidity and mortality in patients with 
A-V block who have received pacemakers. This report reviews the status 
of such patients to determine the natural history of this disorder after 
permanent pacemaker implantation, the causes of late morbidity and 
mortality and the changes in mortality that occurred during the fol- 
low-up period. Survival of this population group was also compared with 
that of the U.S. population matched for age, race and sex. 
Methods 
The records of all adult patients who received permanent pacemakers at the 
University of Michigan Medical Center from 1961 through 1974 were reviewed. 
Many of the patients have been the subject of previous reports from this insti- 
tution.P1l Since 1965, all patients have been followed up in a pacemaker clinic. 
Data on the history, clinical course, specific arrhythmias seen and follow-up 
findings were transferred to computer tape. Survival curves were determined 
with the life table method12J3 utilizing the Michigan Interactive Data Analysis 
System (MIDAS)14 and the Interactive Graphic Survival Analysis System 
(IGSAS).15 For each patient survival time was calculated from the date of the 
first pacemaker implantation until death or the end of the observation period, 
March 1,1976. For the one patient who was lost to follow-up, survival was cal- 
culated from the date of implantation to the date of last follow-up. 
Patient selection: The study population consisted of 246 adult patients who 
received their initial pacemaker at the University of Michigan Medical Center 
for an A-V conduction disturbance during the years specified. Patients with 
bifascicular block and syncope, but without documentation of complete A-V 
block, and two patients with atrial fibrillation and advanced second degree block 
500 March 1978 The American Journal of CARDIOLOGY Volume 41 
NATURAL HISTORY OF ATRIOVENTRICULAR BLOCK-SIMON AND ZLOTO 
were also included. Fifty-seven patients who underwent 
pacing for sinus node disease, hypersensitive carotid sinus 
syndrome or drug-resistant ventricular tachycardia, 20 pa- 
tients in the pediatric age group (14 years or less) and 19 pa- 
tients who received their initial pacemaker elsewhere were 
excluded. 
Derivation of survival data: The Breslow’s generalized 
Kruskal-Wallis Test was utilized to determine if the survival 
distribution differed across strata for any single preimplan- 
tation variable.16 The survival data for the “control” U.S. 
population were derived from abridged life tables for race and 
sex found in reports of the vital statistics of the United States 
from 1962 to 1973.1731s Each individual study patient was 
matched to a life table specific to year of initial implantation, 
sex and race. A t statistic was then computed to test the null 
hypothesis that the mean of the differences between the sur- 
vival times of the patients and control subjects was zero. This 
was computed for the entire population and for each age 
stratum used (less than 65, -65 to 74 and more than 74 
years). 
Classification of heart disease: The etiology of the heart 
disease associated with the conduction disturbance was in- 
ferred from the available clinical data. Arteriosclerosis was 
accepted as a cause of disease only if the patient had a myo- 
cardial infarction documented by enzyme or electrocardio- 
graphic criteria or definite angina pectoris. Rheumatic heart 
disease was considered a cause if the patient had cardiac valve 
disease, usually of both the aortic and the mitral valves, a 
positive history of acute rheumatic fever or pathologic evi- 
dence of it at the time of operation or autopsy. Isolated aortic 
valve disease was considered a cause when appropriate 
physical findings were accompanied by a negative history for 
rheumatic fever and no pathologic changes of rheumatic heart 
disease at operation or autopsy were found. Patients with a 
faint systolic ejection murmur alone were not classified in this 
category. Patients with calcific aortic stenosis and idiopathic 
aortic insufficiency, as well as those with aortic valve disease 
secondary to other disease processes (for example, ankylosing 
spondylitis), were included in this category. Patients were 
judged to have cardiomyopathy if they had severe generalized 
cardiomegaly with or without congestive heart failure before 
pacing and if no other apparent cause for the cardiomegaly 
was evident. Congenital heart disease was diagnosed on the 
basis of the usual clinical, cardiac catheterization and surgical 
criteria. Hypertensive heart disease was defined as radio- 
graphic cardiomegaly or evidence of left ventricular hyper- 
trophy in the electrocardiogram combined with repeated re- 
cordings of blood pressure greater than 160/90 mm Hg. 
When a patient had more than one form of heart disease, 
the apparent dominant etiology at the time of initial im- 
plantation was utilized for classification purposes. Patients 
whose condition did not satisfy the criteria for any of the 
categories cited were classified under “idiopathic.” Patients 
in this category were free of hypertension, had no antecedent 
myocardial infarction or angina pectoris, had no significant 
murmurs and had a normal heart size or only slight cardio- 
megaly without congestive heart failure at implantation. 
Determination of cause of death: The method for de- 
termining the cause of death was similar to that previously 
described.lg Details concerning the circumstances of death 
were obtained by interviewing the patient’s physician, family 
members or other informed witnesses. Hospital, autopsy and 
medical examiner records and terminal electrocardiograms 
were obtained whenever feasible. Available pacing system 
components were retrieved for electronic analysis after death 
whenever possible. 
Sudden death was defined as death within 1 hour of the 
onset of symptoms20; for most of the patients included here, 
death was apparently instantaneous or nearly so. Definite 
congestive heart failure was diagnosed on the basis of exam- 
ination of available records and utilization of the criteria of 
McKee et a1.21 Two or more of the following signs and symp- 
toms were required: exertional dyspnea, paroxysmal nocturnal 
dyspnea, neck vein distension, cardiomegaly, rales, pulmonary 
edema, third sound gallop or positive hepatojugular reflux or 
weight loss of 4.5 kg or more in response to treatment. The 
minor criteria of McKee were not utilized. 
Type of pacemaker implant: From 1961 to 1965, every 
patient received an epicardial lead implant through a left or 
anterior thoracotomy under general anesthesia. Since 1965 
TABLE I 
Major Symptomatic Disease States Before Initial Pacemaker Implantation Correlated Wlth Year of Implantation’ 
Diagnosis 
1961-64 1965-69 1970-74 Total 
(no. = 51) (no. = 103) (no. = 92) (no. = 246) P 
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FIGURE 1. Survival after initial pacemaker implantation. The numbers 
in parentheses beside each 2 year point signify the number of patients 
remaining at each interval. 
two thirds of the patients have had the transvenous approach 
as the implantation method of choice. During the follow-up 
period pacing was performed with General Electric, Med- 
tronic, Cordis or CPI pacing systems. Patients received from 
1 to 12 pulse generators during the follow-up period. 
Results 
The 246 adult patients who received a permanent 
ventricular pacemaker for A-V heart block consisted of 
159 men and 87 women; only 8 were nonwhite. The 
mean age at initial implantation was 66 years (range 16 
to 89); 27 percent were 75 years of age or older and 35 
percent were less than 65 years. 
Before pacemaker implantation, these patients had 
a large prevalence of symptomatic cardiovascular dis- 
ease and other illnesses as well (Table I). Diabetes 
mellitus was present in 24 percent and symptomatic 
chronic obstructive lung disease in 13 percent; 9 percent 
TABLE II 
Survival of Paced Population Over the Time of the 
Follow-up Perlod Compared Wlth Survival of Age-Sex- 
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FlGURE 2. Suvival after initiil pacemaker implantation correlated with 
age at entry. Age as a predictor of mortality was highly significant, but 
when analyzed separately patients in the intermediate age range were 
not significantly different from the very elderly (P = 0.15). 
had a history of major organ malignant neoplasm and 
30 percent were obese. A prior myocardial infarction 
could be documented in only 17 percent; congestive 
heart failure was present in 36 percent. Transient ce- 
rebral ischemic attacks, previous stroke and arterio- 
sclerotic peripheral vascular disease were also common. 
With the exception of obesity, there was no significant 
difference in prevalence of any chronic disease state in 
patients selected for pacing over the period of the study 
(Table I). 
Survival 
The survival rate of the entire group was 61 percent 
at 5 years and 49 percent at 10 years. The highest mor- 
tality rate (12 percent) occurred in the first year (Fig. 
1). Survival was highly correlated with age at initial 
implantation (Fig. 2). Patients under age 65 had a 5 year 
survival rate of 75 percent, whereas only 40 percent of 
those over age 74 lived more than 5 years. Patients in the 
intermediate age group (65 to 74 years) had a 5 year 
survivorship of 61 percent (P = 0.002). For each age 
group the patients with pacing had a shorter survival 
time than the general population (Table II). Mean 
survival time for all patients with pacing was 58 months 
compared with an expected survival time of 73 months 
(P <O.OOl). 
Mortality and year of initial implantation: Mor- 
tality also correlated with the year of initial implanta- 
tion. In Figure 3 the study group is divided into three 
subgroups stratified by the year of initial pacemaker 
implantation-1961 to 1964,1965 to 1969 and 1970 to 
1974. Survival improved progressively in each interval, 
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FIGURE 3. Survival after implantation correlated with year of impian- 
tation. The excessive first year mortality in the 1961 to 1964 period is 
due in part to periofx3ratfve mortality associated with epicardial implants 
used exclusively in that time period. When analyzed separately, the 
1965 to 1969 group did not differ significantly from the 1970 to 1974 




with 5 year survival rates of 50,61 and 71 percent, re- 
spectively, for the three intervals specified (P <0.05). 
The high mortality rate in the first year in the 1961 to 
1964 period is explained in part by the 8 percent 
perioperative mortality rate (4 of 51 patients) associated 
with the transthoracic epicardial operative approach 
available at the time. An additional patient died during 
a second epicardial implantation within the first year. 
No patient in this series died postoperatively when the 
transvenous approach was used.* 
Mortality related to congestive failure and type 
of heart disease: The presence of congestive failure in 
the preimplantation period was also predictive of a 
higher mortality rate (Fig. 4). Those with definite heart 
failure in the preimplantation period had a survival rate 
of 73 and 49 percent at 2 and 5 years, respectively, 
whereas those free of congestive heart failure had a 
survival rate of 87 and 69 percent at these time intervals 
(P <0.04). Other medical conditions did not, as inde- 
pendent variables, appear to affect survival signifi- 
cantly, except for those patients with a preimplantation 
diagnosis of malignant neoplasm (P <O.OOl). Patients 
with systolic or diastolic hypertension and cerebro- 
vascular disease had an insignificantly increased risk 
of death; the presence of diabetes mellitus, obesity, 
chronic obstructive lung disease, hyperlipidemia, 
l At this institution in the same time period one patient with per- 
manent pacing for sinus node disease died of an acute myocardiai in- 
farction and two patients with pacing for drug-refractory ventricular 
tachycardfa died of recurent ant@rm@ within 14 days of transvenous 
pacemaker implantation; these patients were not included in our 
analysis because their indication for pacing was not A-V block. 
i 
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FIGURE 4. Survival after initial pacemaker implantation correlated with 
the presence of congestive heart failure (CHF) before implantation. 
chronic renal disease or peripheral vascular disease did 
not increase the rate of late mortality. 
The etiology of underlying heart disease did correlate 
with a greater late mortality (Fig. 5). Patients with 
ischemic or hypertensive heart disease had the poorest 
survival rate, only 40 percent living beyond 60 months. 
The 111 patients (45.5 percent) with “idiopathic” dis- 
ease did far better; 87 and 72 percent survived 24 and 
60 months, respectively. Patients with isolated aortic 
valve disease and rheumatic heart disease had an in- 
termediate survival rate. There were two deaths by 42 
months in the small group of seven patients with con- 
genital heart disease, six of whom had iatrogenic com- 
plete heart block. Ten patients with apparent primary 
myocardial disease had a survival rate similar to that 
of the group with aortic valve disease. The relation be- 
tween the etiology of underlying clinical heart disease 
and survival was highly significant (P <0.002). 
By combining variables it is possible, retrospectively, 
to group the patient population into those with a high 
(more than 85 percent) and very low (less than 25 per- 
cent) probability of survival at 5 years. Patients in the 
first category were less than 65 years old at initial im- 
plantation and had no history of myocardial infarction 
or congestive heart failure. Patients in the highest risk 
group were more than 74 years old, and had both angina 
pectoris and myocardial infarction before the initial 
implantation. 
Morbidity and Causes of Late Mortality 
Morbidity: During the course of follow-up, new 
major cardiovascular events were common. Twenty 
patients (9 percent) had an acute myocardial infarction, 
and 27 (11 percent) manifested congestive heart failure 
that had not been present before implantation. Central 
nervous system events (transient ischemic attacks, 
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completed stroke or progressive organic brain syn- 
drome) were noted in 35 patients, and in 12 percent 
stroke was the primary cause of death (Table III). In 
addition, 19 patients (8 percent) had progressive azo- 
temia, 15 had a new malignancy and 24 (10 percent) had 
a major pulmonary event (pneumonia, pulmonary in- 
sufficiency or embolism). 
Causes of death: Forty-two percent of patients died 
of apparent cardiac causes (Table III); over half of these 
died suddenly (in 1 hour or less). Six percent died of 
definite or probable myocardial infarction. There was 
no correlation between the mode of death in those pa- 
tients paced with asynchronous WOO) versus syn- 
chronous (VVI) pulse generators at death, or in those 
from any time period. 
TABLE III 
Causes of Death During Study Interval 
Cardiac 
Sudden death (< 1 hour) 
Congestive heart failure 
Myocardial infarction 
Refractory ventricular tachycardia 
Noncardiac 
Central nervous system 
Cancer 
Other (infection, pulmonary embolism, 
pneumonia, uremia, etc.) 


















FIGURE 5. Correlation between survival and clinically 
apparent etiology of heart disease. Patients with isch- 
emit-hypertensive disease did least well, 27 percent 
dying in the first year. 
The exact cause of death.could not be established in 
19 percent. Patients in this category frequently died 
with multiple illnesses in convalescent facilities and 
clinical data were not sufficient for accurate classifica- 
tion. Many of these patients were found dead, and no 
autopsy or medical examiner reports were available. 
From the limited information available on these latter 
patients, symptomatic cardiovascular disease appeared 
to be the most plausible cause of death in most in- 
stances. Autopsy and pulse generator inspection data 
were obtained in 21 percent of the 109 fatal cases; 36 
percent of the patients died in a hospital, and 13 percent 
in a nursing or convalescent facility. Death was related 
to pacing unit malfunction in at least three patients. 
One patient died with pulmonary edema and the ter- 
minal electrocardiogram documented failure to capture 
and slow idioventricular rhythm. One patient died 
suddenly and the returned pulse generator had no 
output. Sudden death was associated with battery de- 
pletion in the third. 
Discussion 
Contribution of permanent cardiac pacing to 
increased survival of patients with A-V block: 
Several studies are available on the “natural history” 
of A-V block before the era of permanent pacing.22-30 
Although the case selection and follow-up methods in 
these studies differ considerably, the frequently quoted 
mortality rate of approximately 50 percent within the 
first year after the diagnosis of complete A-V block 
seems reasonably accurate. Johansson25 called attention 
to the variations in mortality in the prepacing era in 
relation to age at onset and clinical setting of A-V block. 
Differences in patient population, improvements in care 
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TABLE IV 
Specific Arrhythmias Noted at Time of lnltlal Implantation and Other Descriptors of the Populatlon Correlated Wlth 
Year of Implantation’ 
1961-64 1965-69 1970-74 Total 
no. = 51 no. = 103 no. = 92 no. = 246 P 
no. % no. % no. % no. % Value 
Complete A-V block 42 
Intermittent complete heart 6 
block 
Permanent 34 
Se;;;: pgree A-V block 6 
Type II 
2: 1 block only ‘6 
Premature ventricular beats 11 
Ventricular tachycardia or cardiac 5 
arrest 
82.4 a3 80.6 
19.0+ 25 30.1+ 
al.0 58 69.9 
15.7 21 20.4 
3.9 5.8 
11.8 1: 14.6 
22.0 27 26.2 
9.8 a 7.8 
Duration of heart disease (mean yr) 
Duration of intraventricular 
i:; 
conduction defect (mean yr) 
5.5 
2.0 
79.3 198 80.5 <O.OOl 
56.1+ 74 37.4 
43.8 124 62.6 
20.6 48 19.5 
5.3 5 
5.3 5’:: 
10.0 :: 12.2 
30.2 66 26.8 
a.5 19 7.7 
4.9 
1.3 
Duration of A-V block (mean yr) 1.8 1.0 0.9 
l Patients in the earlier years had symptomatic heart disease for a longer period of time than those selected later and had a higher frequency 
of permanent complete A-V block. 










Etiology of Underlylng Heart Disease at Entry as Correlated With Year of Initial Implantation’ 
1961-64 1965-69 1970-74 Total 
(no. = 51) (no. = 103) (no. = 92) (no. = 246) 
no. % no. % no. % no. % 
Idiopathic 24 47.1 53 51.5 39.1 113 
Ischemic-hypertensive 12 23.5 la 17.5 I! 40.2 67 
Rheumatic a 15.7 9 a.7 : a.7 25 
Cardiomyopathy 1 2.0 5 4.9 4.3 
Aortic valve disease 
f ;:8” 
15 14.6 7 7.6 
:9 
Congenital 3 2.9 - - 7 







of congestive heart failure and other medical problems, 
the introduction of palliative operative procedures for 
congenital and valvular heart disease as well as im- 
proved methods of diagnosis (possibly, therefore, in- 
cluding patients at an earlier stage of their disease) 
prevent accurate comparison between patients ‘with 
symptomatic advanced second degree or complete A-V 
block now treated with permanent pacing and “control” 
subjects observed in the 1940 to 1960 period. Even after 
these limitations are acknowledged, the improvement 
in survival in current series is so dramatic that there is 
little doubt that pacing has drastically increased sur- 
vival of patients with this arrhythmia. 
Nevertheless, patients with permanent pacemakers 
implanted for A-V block do continue to experience 
cardiovascular morbidity and mortality and have a 
significantly higher mortality rate than the general U.S. 
population. Although patients with conduction dis- 
turbances are found in every age group, this population 
is, in general, an elderly group with a high prevalence 
rate of chronic diseases including malignant neoplasm, 
obstructive lung disease, diabetes mellitus, peripheral 
and cerebrovascular disease and renal failure. Pro- 
gression of cardiovascular disease, including recurrent 
or new congestive failure, myocardial infarction and 
stroke as well as sudden death, account for over half and 
probably three quarters of all late deaths in these pa- 
tients. In addition, age, antecedent ischemic heart dis- 
ease and congestive heart failure before permanent 
pacing are important predictive factors for early mor- 
tality after successful pacemaker implantation. It is 
unlikely that differences in patient selection played a 
significant role in the higher patient mortality rate in 
the early time period (Table IV). Although patients in 
the 1961 to 1964 period had a greater prevalence of 
syncope, fixed complete A-V block and a slightly longer 
duration of symptoms than those patients in the later 
periods, their age and the prevalence rate of congestive 
heart failure, angina pectoris and prior myocardial in- 
farction were no higher (Table I). For example, 35 per- 
cent of the patients in the earlier time period had A-V 
block or syncope for more than 1 year, whereas only 20 
percent of those in the last time period had symptoms 
of that duration. In fact, the prevalence of ischemic 
heart disease and congestive heart failure was slightly 
greater in the later years (Tables IV and V), perhaps 
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reflecting a trend toward the use of pacing in patients 
who might have been excluded in the earlier time period 
because of the need for a general anesthetic and thora- 
cotomy. Elimination of perioperative mortality asso- 
ciated with general anesthesia as well as improved 
medical and surgical methods of treatment of cardio- 
vascular disease have probably contributed to this im- 
provement in survival. 
Role of pacemaker failure in late deaths: Between 
1961 and 1967 all pacing was performed with asyn- 
chronous (VOO)31 pulse generators whose reliability 
and longevity were inferior to those of currently avail- 
able models.1° Pacing system failure appeared to con- 
tribute to very few deaths in previously reported se- 
ries.1s32-3g In our group sudden death was no more 
common in the early period and was not more common 
in patients paced with asynchronous (VOO) units. Be- 
cause unwitnessed death16J7 and deaths due to un- 
known causes constitute a relatively large part (19 
percent in our series) of all deaths in patients under- 
going pacing and because the pulse generator and pacing 
lead could be inspected in only a few of those who died 
suddenly, some uncertainty must remain concerning the 
role of the pacing system in these deaths. This question 
can be resolved only by a systematic complete exami- 
nation of a selected group of pacing systems after death 
in patients who die suddenly or of unknown causes. 
Mortality findings in our series are similar to those 
previously reported by others.1-3s32-3g The somewhat 
better overall survival rate compared with that of some 
other series may be attributed to a slightly younger 
patient population, a lesser prevalence of prior acute 
myocardial infarction and the later period from which 
the patients were drawn. As in other studies, mortality 
appears to be greatest in the first year after the initial 
pacemaker implantation. 
Role of congestive failure in early mortality and 
indication for sequential atria1 pacing: Congestive 
heart failure as a predictor of earlier patient death de- 
serves special mention. Numerous studies have docu- 
mented improved hemodynamics and disappearance 
of signs and symptoms of congestive failure after per- 
manent pacing.40 However, persistent cardiomegaly,25 
continued dependence on digitalis and diuretic agents, 
and the failure of permanent pacemaker implantation 
to alleviate congestive heart failure in some patients is 
well documented.41 Recurrent or new heart failure was 
common in our series. The rate of death was signifi- 
cantly greater for patients with definite congestive heart 
failure before implantation and, in fact, the mortality 
rate of patients with congestive heart failure and A-V 
block after pacing in our series closely approximates 
that of the Framingham study patients with heart 
failure without A-V block.21 Heart failure that accom- 
panies A-V block is often only partially due to the slow 
rate itself, and impaired ventricular function in patients 
after permanent ventricular pacing is not uncommon. 
There may be a distinct role for A-V synchronous 
(VAT) or sequential pacing (DVI) in patients with 
maintained atria1 function in order to take full advan- 
tage of the atria1 contribution to cardiac output in pa- 
tients with A-V block. Studies by Leinbach et a1.42 and 
others have shown a 20 percent improvement in resting 
cardiac output with this mode of pacing compared with 
ventricular pacing alone. The development of improved 
transvenous atria1 electrodes will be necessary to test 
the possibility of whether such pacing will be beneficial 
to enough patients to warrant its widespread use in 
those with persistent or severe congestive failure and 
A-V block. 
Implications: In our study sudden death was the 
most common mode of death in the population under- 
going pacing for A-V block. Preliminary data indicate 
that ventricular arrhythmias of a serious nature are 
common in such patients (unpublished data). However, 
at this juncture there is little evidence to indicate that 
available antiarrhythmic agents decrease the frequency 
of complex ventricular arrhythmias consistently in this 
population or that they will decrease the incidence of 
late sudden death. 
Several longitudinal studies have demonstrated that 
patients undergoing pacing for A-V block and probably 
for sinus node disease as we1143,44 have a high mortality 
rate in the first 5 years after initial pacemaker implan- 
tation. Certain groups of these patients appear to have 
an especially poor survival rate, including those with 
impaired left ventricular function before implantation, 
those over age 74 at initial implantation and those with 
a prior history of ischemic heart disease. 
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